BRIDGEBIO PHARMA INC shareholders Q3 2023

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 225 filers reported holding BRIDGEBIO PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.6%.

BRIDGEBIO PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$160,016,45665.94%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$819,077,80528.79%
Cormorant Asset Management, LP 4,662,530$122,950,9167.17%
Frazier Life Sciences Management, L.P. 2,725,949$71,883,2754.77%
Octagon Capital Advisors LP 971,639$25,622,1203.94%
M28 Capital Management LP 121,200$3,196,0443.66%
VIKING GLOBAL INVESTORS LP 25,120,991$662,440,5332.69%
BOONE CAPITAL MANAGEMENT LLC 313,381$8,263,8572.61%
Fernwood Investment Management, LLC 235,620$6,213,2992.23%
SOUTHPORT MANAGEMENT, L.L.C. 15,000$395,5502.15%
Sio Capital Management, LLC 222,947$5,879,1121.82%
Logos Global Management LP 500,000$13,185,0001.76%
SPHERA FUNDS MANAGEMENT LTD. 345,537$9,111,8111.66%
HHLR ADVISORS, LTD. 2,782,750$73,381,1181.64%
Perceptive Advisors 1,748,933$46,119,3631.54%
Ikarian Capital, LLC 473,126$12,476,3321.50%
Logos Global Management LP 400,000$10,548,0001.41%
IRONWOOD INVESTMENT MANAGEMENT LLC 64,537$1,701,8411.04%
EAM Global Investors LLC 141,510$3,731,6191.01%
Integral Health Asset Management, LLC 275,000$7,251,7501.00%
External links

This page lists BRIDGEBIO PHARMA INC's shareholders in Q3 2023. To view BRIDGEBIO PHARMA INC's shareholder history, click here.